Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,364
Out of 4,918 analysts
55
Total ratings
68.09%
Success rate
24.39%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $127.29 | -5.73% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $79.33 | +63.87% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $67.16 | +63.79% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $5.50 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $79.28 | -60.58% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $12.67 | +176.24% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $115.89 | +154.55% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $41.13 | +121.25% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $70.57 | -61.74% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $284.91 | -76.48% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $127.29
Upside: -5.73%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $79.33
Upside: +63.87%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $67.16
Upside: +63.79%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $5.50
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $79.28
Upside: -60.58%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $12.67
Upside: +176.24%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $115.89
Upside: +154.55%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $41.13
Upside: +121.25%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $70.57
Upside: -61.74%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $284.91
Upside: -76.48%